Illumina, Inc.
Polynucleotide amplification using CRISPR-Cas systems

Last updated:

Abstract:

A method for amplifying a target nucleic acid including providing a system having a crRNA or a derivative thereof, and a Cas protein or a variant thereof. The crRNA or the derivative thereof contains a target-specific nucleotide region substantially complementary to a region of the target nucleic acid, and contacting the target nucleic acid with the system to form a complex.

Status:
Grant
Type:

Utility

Filling date:

10 Nov 2015

Issue date:

3 Mar 2020